Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125308732 | 12530873 | 2 | F | 20150625 | 20160721 | 20160706 | 20160727 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-053951 | BRISTOL MYERS SQUIBB | 56.66 | YR | M | Y | 65.00000 | KG | 20160727 | CN | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125308732 | 12530873 | 1 | PS | DAKLINZA | DACLATASVIR | 1 | Oral | 60 MG, QD | 1680 | MG | U | 206843 | 60 | MG | FILM-COATED TABLET | QD | |||
125308732 | 12530873 | 2 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 1000 MG, QD | 28000 | MG | U | 0 | 1000 | MG | CAPSULE | QD | |||
125308732 | 12530873 | 3 | SS | SOFOSBUVIR | SOFOSBUVIR | 1 | Oral | 400 MG, QD | 11200 | MG | U | 0 | 400 | MG | TABLET | QD | |||
125308732 | 12530873 | 4 | C | ESKIM | OMEGA-3 FATTY ACIDS | 1 | Oral | 3000 MG, UNK | U | 0 | 3000 | MG | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125308732 | 12530873 | 1 | Chronic hepatitis C |
125308732 | 12530873 | 2 | Chronic hepatitis C |
125308732 | 12530873 | 3 | Chronic hepatitis C |
125308732 | 12530873 | 4 | Hypertriglyceridaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125308732 | 12530873 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125308732 | 12530873 | Hepatic lesion | |
125308732 | 12530873 | Hepatic neoplasm | |
125308732 | 12530873 | Hepatocellular carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125308732 | 12530873 | 1 | 20150529 | 20151112 | 0 | |
125308732 | 12530873 | 2 | 20150529 | 20151112 | 0 | |
125308732 | 12530873 | 3 | 20150529 | 20151112 | 0 | |
125308732 | 12530873 | 4 | 20140701 | 0 |